Trial Profile
MK-3475 in Combination With Standard RCHOP Therapy for Previously Untreated Diffuse Large B-cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Pembrolizumab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Lymphoma
- Focus Adverse reactions
- 06 Jun 2023 Results of 5-year follow-up, presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
- 08 Dec 2020 Results of long term follow up and analysis of the mechanism of Pdl-1 tumor expression, presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology
- 09 Oct 2019 Status changed from recruiting to completed.